speb/financial-data huggingface dataset:
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -281039000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: 111000000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: 1000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Net PPE: 2018509000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -26819000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 139588000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 3120995000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Non Current Accrued Expenses: 0.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 0.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 28598000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 11128000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 618747000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Normalized Income: 161324877.46
INDOFARM.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 405825000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Operating Income: 529035000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Operating Revenue: 3746875000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 48051600.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -10000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 48920000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 111000000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 49629000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 10000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 281039000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: -3000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -10000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 3386000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 21133000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Payable: 100516000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 568175000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 11896000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Other Special Charges: 3931000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Payables: 462767000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: 3396000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 91053000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Pretax Income: 238930000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 5287000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -91164000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 836993000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 2284188000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 103136000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 7887000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 7887000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Research And Development: 5290000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 2262805000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 64345000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 247722000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 340828000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Share Issued: 48051600.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Special Income Charges: -12002000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 3170624000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 3120995000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -4022122.54
INDOFARM.NS income_statement (annual, 2024-03-31) — Tax Provision: 84902000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.36
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 2673000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -46398000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Assets: 6479494000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 4007191000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Debt: 2721640000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 3170624000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Total Expenses: 3217840000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 3308870000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2923702000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 934305000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 17730000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 11769000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -11319000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -11319000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Work In Process: 476812000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Working Capital: 1181226000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Write Off: 8071000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Beginning Cash Position: 71380000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -72144000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Change In Inventory: -10631000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Change In Other Current Assets: -25806000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Change In Other Current Liabilities: 14366000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Change In Payable: -1467000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Change In Receivables: -27010000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Change In Working Capital: -50548000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Changes In Cash: -17821000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 13790000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Depreciation: 29041000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Depreciation And Amortization: 24891000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Dividends Received Cfi: 59000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — End Cash Position: 53569000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Financing Cash Flow: -29055000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Free Cash Flow: -341000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -342000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: -1000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Interest Paid Cff: -58851000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Interest Received Cfi: 767000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Investing Cash Flow: -60569000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 13790000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 13790000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net Income From Continuing Operations: 48585000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net Issuance Payments Of Debt: 19356000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net Long Term Debt Issuance: -70578000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net Other Financing Charges: 1000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 8709000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: -72144000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 89934000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Operating Cash Flow: 71803000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 58487000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Pension And Employee Benefit Expense: -1222000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Provisionand Write Offof Assets: -530000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: -72144000.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
INDOFARM.NS cash_flow (quarterly, 2024-09-30) — Taxes Refund Paid: -7516000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1134949000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 331918000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — +Total Revenue: 3871892000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 1299666000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 324927000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 324927000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1077715000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1077715000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -961828000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -961828000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1913384000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1913384000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -68435000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -68435000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Amortization: 18401000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 18401000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 13936000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 13936000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 41310175.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 41317737.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Basic EPS: 5.70
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 3.27
INDOFARM.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 140560000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1126444000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1126444000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -268500000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 14541000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 14541000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 480516000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 480516000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 595963000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 595963000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1107330000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1107330000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 458215000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 458215000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 137748000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 137748000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -81128000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -46079000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 23949000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Change In Payable: -25554000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 104098000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -24714000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 455402000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Common Stock: 480516000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 480516000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 5313471000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5313471000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 2018384000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 100287000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 100287000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 2262379000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 813582000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Current Assets: 4611656000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4611656000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 3510000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 3510000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1141770000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1141770000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1145280000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1145280000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1650953000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1650953000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 52403000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 52403000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Depreciation: 108148000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 108148000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 108148000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 30046000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 108148000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 30046000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 41310175.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 41317737.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Diluted EPS: 5.70
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 3.27
INDOFARM.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 135109000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 53000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — EBIT: 500781000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — EBIT: 170289000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — EBITDA: 608929000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — EBITDA: 200335000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — End Cash Position: 595963000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1547000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1547000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 679309000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 487259000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 487259000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 261519000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -240000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 193000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 100905000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 67248000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 67248000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1146150000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1146150000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 3130371000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3130371000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Gross Profit: 1609513000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 486084000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Interest Expense: 239127000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 51584000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 239127000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 51584000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Interest Income: 17557000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 17557000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -239127000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 17466000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Inventory: 1729655000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 1729655000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 7033250000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7033250000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -753926000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 15483000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 15483000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 2018384000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 105217000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 105217000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 11031000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 11031000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 578009000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 578009000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 589040000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 589040000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 22040000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 22040000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1798423000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1798423000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 2018384000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Net Debt: 1123816000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 1123816000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Income: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Income: 135109000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 135109000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 135109000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 135109000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 135109000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 261654000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 135109000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Interest Income: -239127000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -51584000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -503527000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -985608000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -228699000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -239127000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -51584000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -111001000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 1000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Net PPE: 2168543000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 2168543000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -267919000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -756909000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 5246223000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5246223000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 0.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2959000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2959000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 11756000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 11756000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 608929000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 200335000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Normalized Income: 235468000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 135109000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 530019000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Operating Income: 474564000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Operating Income: 154166000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Operating Revenue: 3871892000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 1299666000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 48051600.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 48051600.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 33925000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 33925000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 4832956000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 67248000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 67248000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 223286000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 1800000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1800000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 26217000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 16123000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 569223000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 177220000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Payable: 119426000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 119426000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Properties: 2068255000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 481544000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 481544000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 511367000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 511367000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Other Special Charges: 11791000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Payables: 453269000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Payables: 453269000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: 13358000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 178814000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 178814000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Pretax Income: 261654000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 118705000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 636000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -268500000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 794693000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 794693000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 2262379000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 813582000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 108148000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 30046000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 7999000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 7999000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Research And Development: 10690000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 2495938000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 2495938000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 581000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 326589000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 427494000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 48051600.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 48051600.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Special Income Charges: -12241000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5313471000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5313471000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 5246223000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5246223000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Tax Provision: 26186000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -16404000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.10
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 2673000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2673000.00
INDOFARM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -52300000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 7618921000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 7618921000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 5891480000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5891480000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1734320000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1734320000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5313471000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5313471000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Total Expenses: 3397328000.00
INDOFARM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1145500000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 2305450000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2305450000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 3007265000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3007265000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 654497000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 654497000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 25487000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 8916000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 8916000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -12054000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -12054000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 447703000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 447703000.00
INDOFARM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2960703000.00
INDOFARM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2960703000.00
INDOFARM.NS income_statement (annual, 2025-03-31) — Write Off: 450000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 316609000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 962611000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 48085841.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.13
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 544231000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 29878000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 29878000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 48085841.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.13
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 54337000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — EBIT: 119310000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 149188000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 418380000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 44119000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 44119000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Income: 54337000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 54337000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 54338000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 54337000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 54337000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 54338000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -44119000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -44119000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 149188000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 54337000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 101771000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 962611000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 17539000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 152099000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 75191000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 544231000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 29878000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 20853000.00
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.28
INDOFARM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 860840000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 316107000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 1038947000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 320827000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1249686000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 24868000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 47931731.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.04
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 11929000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 480516000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 742095000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1003163000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 480516000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5417658000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 138184000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 625563000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 4752834000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1346000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1240428000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1241774000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1785399000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 59070000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 30425000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 30425000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 47931731.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.04
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — EBIT: 115836000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 146261000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 74805000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2206856000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 413384000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 44138000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 44138000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1775342000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 7206357000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 24868000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 10583000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 548271000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 558854000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 24835000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1046604000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Income: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -44138000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -44138000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 2206856000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 5342853000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 18146000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 146261000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 49849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 97277000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1038947000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 48051600.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 171198000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 10294000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 4937142000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3097000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: -1000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 18561000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 147807000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2068672000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 550772000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 261068000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 341084000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 71698000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 625563000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 30425000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 48051600.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5417658000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 5342853000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 21849000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 2673000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 7847536000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5965929000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1800628000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5417658000.00
INDOFARM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 941670000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2429878000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 3094701000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 644479000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 20257000.00
INDOFARM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 2967435000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 3391610000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 10587190000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 48051600.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.16
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 6147900000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 304250000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 304250000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 48051600.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.16
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 555640000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — EBIT: 1223670000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 1527920000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 4439290000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 437960000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 437960000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Income: 555640000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 555640000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 555650000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 555640000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 555640000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 555650000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -437960000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -437960000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1527920000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 555640000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 1047680000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 10587190000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 175990000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1799390000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 785710000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6147900000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 304250000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 230060000.00
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.29
INDOFARM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 9539510000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1349832000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 377953000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 4400205000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1339928000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 313692000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 313692000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1197671000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1197671000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 16637000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 16637000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 48167956.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 1.81